Latest News

Poor countries must not be forgotten in the Covid-19 battle, Unitaid director warns

Founded more than a dozen years ago, Unitaid has received more than $3 billion in donations for its work to research and identify solutions to such tenacious diseases as HIV/AIDS, tuberculosis, and malaria.

The global organization, which is hosted by the World Health Organization, has helped lower prices and to widen access to various medicines to vulnerable populations through its work with the Medicines Patent Pool, which licenses treatments from drug makers. In keeping with that mission, Unitaid recently endorsed the idea of having the WHO create a voluntary pool to collect intellectual property, which would gather patents, regulatory test data and other information to ensure “equitable access” to vaccines, treatments, and other medical products for combating Covid-19.

Read the rest…

Source link

Related posts

From the pathophysiology of the human lung alveolus to epigenetic editing: Congress 2018 highlights from ERS Assembly 3 "Basic and Translational Science."


Penn State researchers receive CDC grant to study effects of coal dust on lung disease in miners


Scott Gottlieb to return to American Enterprise Institute to focus on drug pricing


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World